Isma Benattia, MD, MBA, currently serves as the Vice President of Research & Development Strategy & Business Operations at Amgen where she focuses on integrating the vast array of data and analytic resources into the planning and execution of Amgen’s research and development programs, transforming the speed, efficiency, and impact of their work.
She is very passionate about patient involvement in the Research & Development of innovative medicines, the life-cycle management of marketed products, and is working extensively with various stakeholders to accelerate access to medicines. In addition, Benattia is knowledgeable and skilled in Big Data application in life sciences.
Before her current role, Benattia served as the VP of Medical Affairs of Europe, Latin America, Middle-East, Canada (ELMAC) regional Headquarters and affiliate Medical Teams, across all therapeutic areas where she built capabilities and partnerships which have contributed to the success of Amgen’s European business. Before that role, she was responsible for advancing Amgen’s expertise and leadership in Global Patient Safety & Labeling.
With more than 20 years of pharmaceutical industry experience, she has held various roles with increasing levels of responsibility in different organizations. Prior to joining Amgen, she served as Vice President and Head of Safety Surveillance and Risk Management at Sanofi Genzyme and Executive Vice President with Pfizer Consumer Health Care. She has also worked in Clinical Development, Medical Affairs, and Executive Management at Wyeth Pharmaceuticals and Eli Lilly France.
Benattia earned a Master of Business Administration at the Massachusetts Institute of Technology Sloan School of Management and a Master in Bioethics from the University of Pennsylvania. She received her medical degree in Psychiatry from Faculte de Medecine d’Alger and Faculte de Medecine Pitié-Salpêtrière University Hospital (Faculty Pierre et Marie Curie).
Celebrating 25 years of innovation! 25.kgi.edu.